TRPV1 and rheumatoid arthritis: The translational relevance of these findings is underscored by the growing clinical interest in TRPV1-targeted therapies for pain conditions such as rheumatoid arthritis and orofacial pain, where TRPV1 antagonists have shown efficacy in reducing both pain and inflammation [14].